FORT WORTH, TX, FEBRUARY 9, 2011 – Healthpoint today announced that its Hydrofera Blue® Bacteriostatic Dressing distribution agreement with Hydrofera, LLC will not be extended. While the distribution rights are being transferred by Hydrofera, LLC to a new partner, Healthpoint will continue fulfilling distributor orders for the near term to support clinicians and patients during the transition. Supply shortages are not anticipated during the transition period.
“This is consistent with the evolution of our strategic operating plan and allows Healthpoint to further increase its focus on supporting the wound care community by researching, developing and commercializing novel pharmaceuticals, biologics and advanced matrix technologies,” said Travis Baugh, President and Chief Operating Officer of Healthpoint.
Healthcare professionals who would like additional information may contact Healthpoint’s Customer Care department at 1-800-441-8227.
About HEALTHPOINT, Ltd.
Since 1992, HEALTHPOINT has been dedicated to innovative technologies for the prevention and treatment of acute, chronic and burn-related wounds. The company is presently focused on the research and development of novel biologics and pharmaceuticals intended to improve clinical and quality of life outcomes. Currently marketed products include Collagenase SANTYL® Ointment and OASIS® Wound Matrix. HEALTHPOINT is also committed to advancing the care and treatment of wounds through support of industry leading continuing education from THE WOUND INSTITUTE®. To learn more about this comprehensive and award winning educational resource, please visit TheWoundInstitute.com. HEALTHPOINT is a DFB Pharmaceuticals, Inc. affiliate company, and is based in Fort Worth, Texas. For more information, visit the HEALTHPOINT website at www.healthpoint.com.
Healthpoint and design, SANTYL, THE WOUND INSTITUTE and THEWOUNDINSTITUTE.COM are registered trademarks of
OASIS is a registered trademark of Cook Biotech, Inc.
HYDROFERA BLUE is a registered trademark of Hydrofera, LLC.